General
publicado em 03/10/2012 às 18h50:00
   Dê o seu voto:

Free medicine for asthma benefit over 260 thousand people

Action is part of the Brazil Affectionate, released in May, which was sanctioned law on Wednesday by President

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Luis Oliveira/Ascom/MS
President Dilma Rousseff sanctions the Benefit of Overcoming Extreme Poverty in early childhood, in a ceremony at the Presidential Palace
  « Previous
next »  
President Dilma Rousseff sanctions the Benefit of Overcoming Extreme Poverty in early childhood, in a ceremony at the Presidential Palace

The inclusion of three new drugs for asthma in Health Has No Price, integral action of the Popular Pharmacy Program, resulted in a significant increase in the number of beneficiaries with free medicines from June this year.

In May, 48,495 people had access to anti-asthmatics, and from June to September, were 263,227, an increase of 443%. Data are from the Ministry of Health According to the folder, the inclusion of three new drugs for asthma in Popular Pharmacy Program resulted in a significant increase in the number of beneficiaries with free medicine.

The action is part of Brazil Affectionate program, launched in May, whose law was enacted on Wednesday (3) by President Dilma Rousseff. The Affectionate Brazil aims to take the misery children 0-6 years of age.

After the gratuity of drugs for hypertension and diabetes, the sale of antiasthmatic was the fastest growing in popular pharmacies. Due to this increased demand, the federal government decided to include new drugs in the Popular Pharmacy Program. Thus began to be offered for free in 10 asthmatics three presentations: ipratropium bromide, beclomethasone dipropionate and salbutamol sulphate. Across the country, more than 20,000 pharmacies, including public and private, who distribute the drugs.

In addition to increasing access, supply of medicines has helped to reduce the number of hospitalizations for the disease. Asthma is among the leading causes of hospitalization among children in this age group. In 2011, the total of 177,800 hospitalizations in the Unified Health System (SUS) as a result of the disease were 77 100 children in this age group. Search Vigitel (Surveillance and Risk for Chronic Diseases Protection Telephone Interviews), the Ministry of Health, indicates that asthma kills 2500 people a year in the country.

Source: Isaude.net
   Palavras-chave:   Asthma    Health Has No Price    Pulmonology    Popular Pharmacy Program    Dilma Rousseff    Brazil Affectionate   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Free medicine for asthma benefit over 260 thousand people
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Free medicine for asthma benefit over 260 thousand people


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
Asthma    Health Has No Price    pulmonology    Popular Pharmacy Program    Dilma Rousseff    Brazil Affectionate   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.